Cartherics to present at the CIMT Annual Meeting in Germany

By Karen Loudon / May 2, 2023
Cartherics is pleased to announce that PhD Candidate, Van To, will be presenting at the Association for Cancer Immunotherapy’s 20th...
Read More

Cartherics grants Shunxi Licence for CAR-T Cell Therapy for Ovarian Cancer in Greater China

By Karen Loudon / April 28, 2023
Melbourne, Australia, 28 April 2023 –  Cartherics Pty Ltd ("Cartherics"), a biotechnology company developing immune cell therapies for the treatment...
Read More

Cartherics’ offsite provides the opportunity to connect, engage and grow

By Karen Loudon / April 14, 2023
Cartherics recently held a company offsite at the RACV Healesville Country Club and Resort. Nestled in the beautiful Yarra Valley...
Read More

Cartherics proudly supports the White Shirt Campaign

By Karen Loudon / April 11, 2023
Cartherics is hosting a White Shirt Day lunch on 8th May to help raise funds and awareness for ovarian cancer....
Read More

Cartherics to present at ThymOz 2023

By Karen Loudon / March 22, 2023
Cartherics will be presenting at the ThymOZ 2023 International Conference on T Cells to be held from 22 -26 March...
Read More

Cartherics to present at prestigious oncology conference in France

By Karen Loudon / March 3, 2023
Cartherics is pleased to announce that Dr Vera Evtimov, Project Manager and Principal Scientist, will be presenting her work in...
Read More

Cartherics to present at Australia Biologics 2023

By Karen Loudon / February 28, 2023
Cartherics is pleased to announce that Dr Madeline Cao, Research Fellow, will be presenting at Australia Biologics 2023 at Crown...
Read More

Peter MacCallum Cancer Centre and Cartherics Announce Collaboration to Develop Autologous CAR-T Cell Therapy for Ovarian Cancer

By Karen Loudon / February 27, 2023
Melbourne, Victoria, Australia 27 February 2023 Peter MacCallum Cancer Centre (“Peter Mac”) and Cartherics Pty Ltd (“Cartherics”) announced today they...
Read More

Cartherics is ‘Turning Teal’ this February in support of ovarian cancer

By Karen Loudon / February 22, 2023
Cartherics is delighted to be hosting a Teal Tea this February to raise awareness and funds for people affected by...
Read More

Cartherics celebrates PhD student’s success

By Karen Loudon / February 6, 2023
Cartherics is delighted to announce that Saleh Almasabi has successfully completed his PhD Candidature. Saleh’s research thesis, ‘The role of...
Read More

CGTLive Interview: New Frontiers in Allogeneic Cell Therapy

By Karen Loudon / January 20, 2023
Cartherics’ CEO, Professor Alan Trounson, was recently interviewed by CGTLive, to discuss the company’s development of NK cell, T-cell and...
Read More

Cartherics granted first patent in China for multiple development candidates

By Karen Loudon / January 9, 2023
Melbourne, Australia, 09 January 2023 – Cartherics Pty Ltd (“Cartherics”), a biotechnology company developing immune cell therapies for the treatment...
Read More

Cartherics to Present at Biotech Showcase™ 2023

By Karen Loudon / December 22, 2022
Cartherics to Present at Biotech Showcase™ 2023 Dr Ian Nisbet will provide a presentation on Cartherics’ technology and development program...
Read More

Message from the CEO – December 2022

By Karen Loudon / December 14, 2022
This year has been an exciting and productive one for Cartherics. We opened our new and impressive research and development...
Read More

Breaking the Mould: Building a Research-Based Biotech Company in Australia from Scratch

By Karen Loudon / December 7, 2022
Ian Nisbet and Alan Trounson, AO Australia is a very challenging environment for early-stage biotechnology companies. Risk capital is hard...
Read More